Stock listing
NASDAQ:ACOR Acorda Therapeutics Inc Stock
Follow Acorda Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ACOR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ACOR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Acorda Therapeutics Inc on 6ix
- Calls
- 10 calls with a replay · 10 with a transcript · latest Nov 13, 2023
- Decks
- 5 decks · latest Nov 13, 2023
Where Acorda Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACOR · This page · Delisted | NASDAQ | United States | USD |
| OTC:ACORQ · Delisted | OTC | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Acorda Therapeutics (ACOR) Q3 2023 Earnings Call | Mon, Nov 13, 2023 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q2 2023 Earnings Call | Tue, Aug 08, 2023 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q1 2023 Earnings Call | Thu, May 11, 2023 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q4 2022 Earnings Call | Thu, Mar 09, 2023 · 8:30 AM ET | Replay |
| Acorda Therapeutics (ACOR) Q3 2022 Earnings Call | Tue, Nov 01, 2022 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q1 2022 Earnings Call | Wed, May 11, 2022 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q4 2021 Earnings Call | Wed, Mar 09, 2022 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 4:30 PM ET | Replay |
| Acorda Therapeutics (ACOR) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2023 Earnings Presentation | Earnings | 19 slides | Nov 13, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 20 slides | Aug 8, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 20 slides | May 11, 2023 |
| Q4 2022 Earnings Presentation | Earnings | 20 slides | Mar 9, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 25 slides | Nov 1, 2022 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Burkhard Blank Other companies: MannKind Corporation (EVP Chief Medical Officer · Since at least May 24, 2023) | CMO and Head of R&D · Jul 1, 2016 – Mar 3, 2021 · Past |
| Standish Fleming Other companies: Ambit Biosciences Corp (Director · May 15, 2013 – May 15, 2014 · Past) | Director · Feb 9, 2006 – Feb 15, 2006 · Past |
| Andrew Blight | Chief Scientific Officer · Jul 19, 2013 – Mar 1, 2017 · Past |
| Catherine D Strader | Director · Feb 17, 2017 – Jun 2, 2021 · Past |
| Michael A Gesser | Chief Financial Officer · Nov 8, 2021 – Nov 8, 2021 · Past |
| Peder Jensen | Director · Jun 10, 2022 – Jun 22, 2023 · Past |
| Sandra Phd Panem | Director · Jun 19, 2019 – Jun 22, 2023 · Past |
Log in to ask 6ix AI your own questions about Acorda Therapeutics Inc.